These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Fatal evolution of Chagas'disease/Aids co-infection: diagnostic difficulties between myocarditis reactivation and chronic chagasic myocardiopathy]. Almeida EA; Silva EL; Guariento ME; Souza ML; Aoki FH; Pedro Rde J Rev Soc Bras Med Trop; 2009; 42(2):199-202. PubMed ID: 19448942 [TBL] [Abstract][Full Text] [Related]
23. Benznidazole in Cerebrospinal Fluid: a Case Series of Chagas Disease Meningoencephalitis in HIV-Positive Patients. Fernández ML; Marson ME; Mastrantonio GE; Corti MA; Fleitas U; Lloveras SC; Lista N; Priarone MM; Domínguez C; Garcia-Bournissen F Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361290 [TBL] [Abstract][Full Text] [Related]
24. Molecular diagnosis and treatment monitoring of congenital transmission of Trypanosoma cruzi to twins of a triplet delivery. Burgos JM; Altcheh J; Petrucelli N; Bisio M; Levin MJ; Freilij H; Schijman AG Diagn Microbiol Infect Dis; 2009 Sep; 65(1):58-61. PubMed ID: 19679236 [TBL] [Abstract][Full Text] [Related]
25. Reactivation of chronic Chagas' disease following allogeneic bone marrow transplantation and successful pre-emptive therapy with benznidazole. Altclas J; Sinagra A; Jaimovich G; Salgueira C; Luna C; Requejo A; Milovic V; De Rissio A; Feldman L; Riarte A Transpl Infect Dis; 1999 Jun; 1(2):135-7. PubMed ID: 11428981 [TBL] [Abstract][Full Text] [Related]
26. Decreased intensity of inflammation in benznidazole-treated mice inoculated with Trypanosoma cruzi I stocks from Mexico and persistence of circulating parasites. Cruz-Zetina G; del Rio-Rodriguez R; Ramos-Ligonio A; López R; Monteon V Am J Trop Med Hyg; 2012 Oct; 87(4):671-4. PubMed ID: 22890036 [TBL] [Abstract][Full Text] [Related]
27. Prevention of congenital Chagas through treatment of girls and women of childbearing age. Moscatelli G; Moroni S; García-Bournissen F; Ballering G; Bisio M; Freilij H; Altcheh J Mem Inst Oswaldo Cruz; 2015 Jun; 110(4):507-9. PubMed ID: 25993401 [TBL] [Abstract][Full Text] [Related]
28. [Protective effect of benznidazole against parasite reactivation in patients chronically infected with Trypanosoma cruzi and treated with corticoids for associated diseases]. Rassi A; Amato Neto V; de Siqueira AF; Ferriolli Filho F; Amato VS; Rassi Júnior A Rev Soc Bras Med Trop; 1999; 32(5):475-82. PubMed ID: 10881079 [TBL] [Abstract][Full Text] [Related]
29. Changes in the immune response after treatment with benznidazole versus no treatment in patients with chronic indeterminate Chagas disease. Vallejo A; Monge-Maillo B; Gutiérrez C; Norman FF; López-Vélez R; Pérez-Molina JA Acta Trop; 2016 Dec; 164():117-124. PubMed ID: 27619190 [TBL] [Abstract][Full Text] [Related]
30. Diagnosis and Treatment of Congenital Chagas Disease in a Premature Infant. Alarcón A; Morgan M; Montgomery SP; Scavo L; Wong EC; Hahn A; Jantausch B J Pediatric Infect Dis Soc; 2016 Dec; 5(4):e28-e31. PubMed ID: 27466398 [No Abstract] [Full Text] [Related]
31. Co-infection Trypanosoma cruzi/HIV: systematic review (1980-2010). Almeida EA; Ramos Júnior AN; Correia D; Shikanai-Yasuda MA Rev Soc Bras Med Trop; 2011; 44(6):762-70. PubMed ID: 22231251 [TBL] [Abstract][Full Text] [Related]
32. [Evaluation of an specific treatment for Trypanosoma cruzi in children, in the evolution of the indeterminate phase]. Silveira CA; Castillo E; Castro C Rev Soc Bras Med Trop; 2000; 33(2):191-6. PubMed ID: 10881133 [TBL] [Abstract][Full Text] [Related]
33. In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole. Murta SM; Romanha AJ Parasitology; 1998 Feb; 116 ( Pt 2)():165-71. PubMed ID: 9509026 [TBL] [Abstract][Full Text] [Related]
34. [Recommendations for diagnosis, treatment and follow-up of the Trypanosoma cruzi: human immunodeficiency virus co-infection]. Rev Soc Bras Med Trop; 2006; 39(4):392-415. PubMed ID: 17119760 [No Abstract] [Full Text] [Related]
35. New advances in the management of a long-neglected disease. Urbina JA Clin Infect Dis; 2009 Dec; 49(11):1685-7. PubMed ID: 19877968 [No Abstract] [Full Text] [Related]
36. Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection. Freitas VLT; Novaes CTG; Sartori AMC; Carvalho NB; Silva SCVD; Nakanishi ÉS; Salvador F; Castro CN; Bezerra RC; Westphalen EVN; Oliveira CMR; Busser FD; Ho YL; Buccheri R; Bonilla C; Shikanai-Yasuda MA PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011961. PubMed ID: 38408095 [TBL] [Abstract][Full Text] [Related]
37. Usefulness of the polymerase chain reaction for monitoring cure of mice infected with different Trypanosoma cruzi clonal genotypes following treatment with benznidazole. Miyamoto CT; Gomes ML; Marangon AV; de Araújo SM; Bahia MT; Martins-Filho OA; de Lana M; de Ornelas Toledo MJ Exp Parasitol; 2008 Sep; 120(1):45-9. PubMed ID: 18533149 [TBL] [Abstract][Full Text] [Related]
38. Benznidazole shortage makes chagas disease a neglected tropical disease in developed countries: data from Spain. Navarro M; Norman FF; Pérez-Molina JA; López-Vélez R Am J Trop Med Hyg; 2012 Sep; 87(3):489-90. PubMed ID: 22826485 [TBL] [Abstract][Full Text] [Related]
39. Tumour-like chagasic encephalitis in AIDS patients: an atypical presentation in one of them and outcome in a small series of cases. Sica RE; Gargiullo G; Papayanis C Arq Neuropsiquiatr; 2008 Dec; 66(4):881-4. PubMed ID: 19099131 [No Abstract] [Full Text] [Related]
40. Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease. Moreno M; D'ávila DA; Silva MN; Galvão LM; Macedo AM; Chiari E; Gontijo ED; Zingales B Mem Inst Oswaldo Cruz; 2010 Nov; 105(7):918-24. PubMed ID: 21120364 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]